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SUmmAry – Occlusion of the initial segment of internal carotid artery is the most common 
reason for vascular events in the brain. The purpose of this study was to investigate the effect of one-
year treatment with atorvastatin on intima-media thickness (imT) of carotid arteries as a measure of 
atherosclerosis in stroke patients. in this prospective interventional study, 44 patients with ischemic 
stroke were investigated. Patients were treated with atorvastatin 40 mg once a day for one year. imT 
of carotid arteries was measured by extracranial doppler ultrasonography in the distal part of the com-
mon carotid artery at the beginning of the study, at 6 months and one year of treatment with atorvas-
tatin. The imT of both right and left carotid arteries decreased after 6- and 12-month atorvastatin 
treatment. Based on the results of this study, long-term administration of atorvastatin was associated 
with reduction in carotid artery imT in patients with ischemic stroke. Such a decrease in imT may 
prevent subsequent stroke or cardiovascular events in these patients.
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Introduction
Stroke as an extremely frequent disorder accounts 
for considerable numbers of chronic disability, demen-
tia and deaths cases in the United States1. Therefore, it 
is essential to reduce the risk of stroke by applying pre-
ventive methods. moreover, rehabilitation strategies 
are important in reducing disabilities in these patients2. 
ischemic and hemorrhagic strokes are the two main 
subgroups of stroke with the former subgroup con-
taining almost 80% of cases. ischemic stroke is classi-
fied into cardioembolic, atherosclerotic, lacunar, and 
other subtypes based on etiologic factors3. Several risk 
factors have been recognized for stroke based on etio-
logic classes, among them hypertension, hyperlipid-
emia, and atrial fibrillation4. Occlusion of carotid ar-
tery by carotid plaques is an underlying cause of stroke. 
These plaques are usually slow-developing or dormant 
for long times but may abruptly change and cause rup-
tures, fissures, or endothelial corrosions resulting in 
confined or distant obstructions5. Carotid intima-me-
dia thickness (imT), as measured by high-resolution 
ultrasound techniques, has been generally used as an 
indicator of atherosclerosis. Several studies have shown 
the predictive value of imT in vascular events inde-
pendently of the routine vascular risk factors6. Statins 
are 3-hydroxy-3-methylglutaryl coenzyme A reduc-
tase inhibitors, which are widely used as effective lipid 
lowering drugs. These drugs can diminish cardiovascu-
lar events in several cardiovascular disorders7. Statins 
have beneficial effects by decreasing ischemia, lower-
ing inflammatory responses and ameliorating athero-
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sclerotic events. These effects might also be reflected in 
a remarkable decrease in imT following administra-
tion of statins8. meta-analyses of available data have 
indicated substantial reduction of imT following 
treatment with some statins such as lovastatin and 
simvastatin9. in the present study, we aimed to evaluate 
the effects of long-term treatment with atorvastatin on 




in the current prospective interventional study, 44 
patients (21 females and 23 males) with ischemic 
stroke were enrolled. Patients were referred to farsh-
chian hospital, hamadan during 2016-2017. All pa-
tients were treated with atorvastatin 40 mg once a day 
for one year. The study protocol was approved by the 
ethics Committee of hamadan University of medical 
Sciences (ethics Code: ir.UmShA.reC.1396.44, 
Clinical Trial Approval number: irCT20170712 
9014n173). written informed consent forms were ob-
tained from all study participants. The inclusion crite-
ria were patient ability to cooperate, history of isch-
emic stroke and age >50 years. exclusion criteria were 
creatinine values >1.5 mg/dL, history of statin use in 
the previous one month, history of hepatic or muscular 
side effects following statin taking, taking anticoagu-
lant or other anti-lipid agents, pregnancy and need for 
endarterectomy or carotid stent.
Measurements
Patients underwent extracranial doppler ultraso-
nography (eCd) with two cylindrical and linear 
probes. imT of carotid arteries was measured by a lin-
ear probe at the frequency of 5-7 mhz in the distal 
part of the common carotid artery at the beginning of 
the study, then at 6 months and one year of treatment 
with atorvastatin. To increase the accuracy, the artery 
wall thickness was measured in three regions and the 
mean values were recorded. data were collected using 
a checklist that included demographic data and chang-
es in the carotid artery imT. 
Statistical analyses
The suitable sample size was determined by G*Power 
3 software considering type i and ii errors of 5% and 
20%, respectively. data were analyzed using SPSS 16.0 
software (iBm, Armonk, ny, USA). Quantitative and 
qualitative parameters were described by mean ± stan-
dard deviation (Sd) and percentage (or proportions), 
respectively. T test was used for assessment of the effects 
of intervention on the corresponding parameters. P val-
ues less than 0.05 were considered significant.
Results
The mean age ± Sd of study participants was 68.6 
years. There was no significant age difference between 
female and male participants (68±8.9 vs. 69.2±10.5, 
p=0.695). The imT of both right and left carotid ar-
teries decreased after 6- and 12-month treatment with 
atorvastatin. Table 1 shows the imT values after treat-
ment with atorvastatin.
we also assessed the effects of treatment on the 
mentioned parameters in male and female subjects 
separately (Table 2). The imT of the right carotid was 
not significantly different before treatment and after 
6-month treatment in female subjects (p=0.229). 
however, 12-month treatment with atorvastatin re-
sulted in a significant decrease in imT of both carotids 
in both male and female subjects.
Discussion
Carotid imT has been recognized as an eminent 
alternative marker of subclinical atherosclerosis10 and 
cardiovascular diseases11 in diverse clinical settings. 
meanwhile, statins have been shown to alleviate ath-
erosclerotic processes and reduce carotid imT9. in the 
current study, we assessed long-term effects of atorvas-
tatin on imT of carotid arteries in patients with previ-
ous ischemic stroke. recurrent stroke is a devastating 
event, which is associated with high mortality and 
morbidity. The pathogenesis of this condition is most 
likely multifactorial and many recurrences cannot be 
explained by the routine risk assessments. however, 
some studies have indicated that common carotid 
imT is an independent predictor of stroke recur-
rence12. furthermore, Lorenz et al. have reported that 
carotid imT is a robust forecaster of imminent vascu-
lar events. notably, the relative risk of each imT 
change was somehow greater for the endpoint stroke 
than for myocardial infarction13. Ultrasound assess-
ment of carotid imT is a noninvasive method for eval-
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uation of the degree of arteriosclerosis, the risk of up-
coming stroke, and appraisal of the efficacy of drug 
therapies14. in the current prospective study, we dem-
onstrated the beneficial effects of atorvastatin in re-
ducing carotid imT at both time points in male sub-
jects.
Our results are in accordance with a previous meta-
analysis, which showed that treatment with atorvas-
tatin significantly decreased carotid imT in Chinese 
patients with type 2 diabetes15. furthermore, fang et al. 
showed that high-dose atorvastatin (40 mg) was supe-
rior to low-dose (10 mg) atorvastatin in reducing ca-
rotid imT15. Based on these results, we only checked 
the effects of high-dose atorvastatin in our cohort of 
patients. Previous studies report controversial results 
regarding the effect of atorvastatin on imT, which 
might be due to short duration of drug administra-
tion15. for instance, kim et al. showed that 6-month 
use of statins amended endothelial function in patients 
with variant angina, but they did not detect significant 
decrease in carotid imT in their patients7. Such dura-
tion-based effects were also demonstrated in our study. 
Although this intervention did not reduce right carotid 
imT in female subjects after 6 months, one-year treat-
ment with atorvastatin significantly decreased imT of 
both arteries in both sexes. Therefore, we conclude that 
long-term administration of atorvastatin increases its 
effects in all patients and might decrease the risk of 
future strokes. however, additional studies are needed 
to verify our results in larger sample sizes. moreover, 
assessment of long-term side effects of atorvastatin is 
needed. The current study had the strength of accurate 
measurement of artery wall thickness in three regions 
of the artery and assessment of patients from a similar 
ethnic group, which is expected to decrease the effects 
of confounding variables. however, our study had some 
limitations including the lack of control group and in-
clusion of patients of distinct age range, which might 
limit the generalizability of the results.
Acknowledgment
The current study was supported by a grant from 
hamadan University of medical Sciences.
References
 1. roger vL, Go AS, Lloyd-Jones dm, Adams rJ, Berry Jd, 
Brown Tm, et al. heart disease and stroke statistics – 2011 
update: a report from the American heart Association. Cir-
culation. 2011 feb 1;123(4):e18-e209. doi: 10.1161/Cir. 
0b013e3182009701
 2. vidovic m, Sinanovic O, Sabaskic L, haticic A, Brkic e. inci-
dence and types of speech disorders in stroke patients. Acta 
Clin Croat. 2011 dec;50(4):491-4.
 3. Adams hP Jr, Bendixen Bh, kappelle LJ, Biller J, Love BB, 
Gordon dL, et al. Classification of subtypes of acute ischemic 
stroke. definitions for use in a multicenter clinical trial. 
Table 1. Intima-media thickness (IMT) values after atorvastatin treatment
Before treatment After 6-month treatment




p value  
(t test)
right carotid imT 0.86±0.19 0.79±0.14 0.001 0.73±0.15 0.001
Left carotid imT 0.92±0.19 0.83±0.15 0.001 0.77±0.13 0.001
Both carotids imT 0.89±0.19 0.81±0.15 0.001 0.75±0.14 0.001
Table 2. Intima-media thickness (IMT) values after treatment with atorvastatin according to patient gender
males females
























0.023 0.75±0.16 0.229 0.80±0.09 0.84±0.17 0.001 0.7±0.14 0.001 0.78±0.7 0.88±0.21 right carotid imT
0.001 0.79±0.11 0.001 0.85±0.10 0.94±0.15 0.001 0.76±0.14 0.008 0.81±0.19 0.9±0.19 Left carotid imT
M. Khazaei et al. Atorvastatin effect on carotid artery IMT in stroke patients
226 Acta Clin Croat, Vol. 59, No. 2, 2020
TOAST. Trial of Org 10172 in Acute Stroke Treatment. 
Stroke. 1993 Jan;24(1):35-41. doi: 10.1161/01.str.24.1.35
 4. Boehme Ak, esenwa C, elkind mSv. Stroke risk factors, 
 genetics, and prevention. Circ res. 2017 feb 3;120(3):472-95. 
doi: 10.1161/CirCreSAhA.116.308398
 5. rothwell Pm. Atherothrombosis and ischaemic stroke. Br 
med J. 2007 feb 24;334(7590):379-80. doi: 10.1136/bmj. 
38964.489051.80
 6. Lorenz mw, von kegler S, Steinmetz h, markus hS, Sitzer 
m. Carotid intima-media thickening indicates a higher vascu-
lar risk across a wide age range: prospective data from the 
 Carotid Atherosclerosis Progression Study (CAPS). Stroke. 
2006 Jan 1;37(1):87-92. doi: 10.1161/01.STr.0000196964. 
24024.ea
 7. kim kh, Cho Sh, yim yr, Lee kJ, yum Jh, yoon hJ, et al. 
effects of low dose versus high dose statin therapy on the 
changes of endothelial function and carotid intima-media 
thickness in patients with variant angina. J Cardiovasc Ultra-
sound. 2013;21(2):58-63. doi: 10.4250/jcu.2013.21.2.58
 8. riccioni G. Statins and carotid intima-media thickness reduc-
tion: an up-to-date review. Curr med Chem. 2009;16(14):1799-
805. doi: 10.2174/092986709788186183
 9. huang y, Li w, dong L, Li r, wu y. effect of statin therapy 
on the progression of common carotid artery intima-media 
thickness: an updated systematic review and meta-analysis of 
randomized controlled trials. J Atheroscler Thromb. 2013;20 
(1):108-21. doi: 10.5551/jat.14001
10. Jung Ch, Baek Ar, kim kJ, kim By, kim Ch, kang Sk, et al. 
Association between cardiac autonomic neuropathy, diabetic 
retinopathy and carotid atherosclerosis in patients with type 2 
diabetes. endocrinol metab (Seoul, korea). dec 2013;28(4): 
309-19. doi: 10.3803/enm.2013.28.4.309
11. Sibal L, Agarwal SC, home Pd. Carotid intima-media thick-
ness as a surrogate marker of cardiovascular disease in diabetes. 
diabetes metab Syndr Obes. 2011 Jan 19;4:23-34. doi: 
10.2147/dmSO.S8540
12. Talelli P, Terzis G, katsoulas G, Chrisanthopoulou A, ellul J. 
recurrent stroke: the role of common carotid artery intima-
media thickness. J Clin neurosci. 2007 nov;14(11):1067-72. 
doi: 10.1016/j.jocn.2006.06.019
13. Lorenz mw, markus hS, Bots mL, rosvall m, Sitzer m. Pre-
diction of clinical cardiovascular events with carotid intima-
media thickness: a systematic review and meta-analysis. Circu-
lation. 2007 Jan 30;115(4):459-67. doi: 10.1161/CirCULA-
TiOnAhA.106.628875
14. Gaarder m, Seierstad T. measurements of carotid intima media 
thickness in non-invasive high-frequency ultrasound images: 
the effect of dynamic range setting. Cardiovascular ultrasound. 
2015 dec 1;13(1):5. doi: 10.1186/1476-7120-13-5
15. fang n, han w, Gong d, Chen Z, fan y. Atorvastatin treat-
ment for carotid intima-media thickness in Chinese patients 
with type 2 diabetes: a meta-analysis. medicine. 2015 
nov;94:44. doi: 10.1097/md.0000000000001920
Sažetak
UČinAk ATOrvASTATinA nA deBLJinU ArTeriJSke inTime mediJe  
U BOLeSnikA S iShemiJSkim mOŽdAnim UdArOm
M. Khazaei, M. Khosravi, Sh. Mazaheri, M. Mazdeh, M. Ghiasian, M. Taheri i S. Ghafouri-Fard
Blokada početnog dijela interne karotidne arterije najčešći je razlog vaskularnih ispada u mozgu. namjera ovoga istraži-
vanja bila je ispitati učinak jednogodišnje terapije atorvastatinom na debljinu intime medije (intima-media thickness, imT) 
karotidnih arterija kao mjere ateroskleroze kod bolesnika s moždanim udarom. U ovoj prospektivnoj intervencijskoj studiji 
ispitana su 44 bolesnika s ishemijskim moždanim udarom. Bolesnici su liječeni atorvastatinom, 40 mg jedanput na dan kroz 
jednu godinu. imT karotidnih arterija mjeren je ekstrakranijskom doppler ultrasonografijom u distalnom dijelu zajedničke 
karotidne arterije na početku istraživanja te nakon 6 mjeseci i 12 mjeseci liječenja atorvastatinom. Zabilježeno je sniženje 
imT i u desnoj i u lijevoj karotidnoj arteriji nakon 6 mjeseci i 12 mjeseci liječenja atorvastatinom. rezultati ovoga istraživa-
nja pokazuju da je dugotrajno uzimanje atorvastatina bilo udruženo sa smanjenjem imT karotidnih arterija u bolesnika s 
ishemijskim moždanim udarom. Takvo sniženje imT moglo bi spriječiti naknadni moždani udar ili kardiovaskularne ispade 
kod ovih bolesnika. 
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